Cholangiocarcinoma of the Gallbladder Completed Phase 1 / 2 Trials for CPI-613 (DB12109)

IndicationStatusPhase
DBCOND0029558 (Cholangiocarcinoma of the Gallbladder)Completed1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01766219CPI-613 in Treating Patients With Advanced or Metastatic Bile Duct Cancer That Cannot Be Removed By SurgeryTreatment